BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Oriuchi N, Higuchi T, Ishikita T, Miyakubo M, Hanaoka H, Iida Y, Endo K. Present role and future prospects of positron emission tomography in clinical oncology. Cancer Sci. 2006;97:1291-1297. [PMID: 17052261 DOI: 10.1111/j.1349-7006.2006.00341.x] [Cited by in Crossref: 64] [Cited by in F6Publishing: 51] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Murphy JM, Armijo AL, Nomme J, Lee CH, Smith QA, Li Z, Campbell DO, Liao HI, Nathanson DA, Austin WR, Lee JT, Darvish R, Wei L, Wang J, Su Y, Damoiseaux R, Sadeghi S, Phelps ME, Herschman HR, Czernin J, Alexandrova AN, Jung ME, Lavie A, Radu CG. Development of new deoxycytidine kinase inhibitors and noninvasive in vivo evaluation using positron emission tomography. J Med Chem 2013;56:6696-708. [PMID: 23947754 DOI: 10.1021/jm400457y] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
2 Scott P. Methods for the Incorporation of Carbon-11 To Generate Radiopharmaceuticals for PET Imaging. Angew Chem Int Ed 2009;48:6001-4. [DOI: 10.1002/anie.200901481] [Cited by in Crossref: 57] [Cited by in F6Publishing: 41] [Article Influence: 4.8] [Reference Citation Analysis]
3 Pinilla I, Gómez León N. [The usefulness of PET/CT in lung cancer]. Radiologia 2009;51:248-60. [PMID: 19406442 DOI: 10.1016/j.rx.2009.01.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
4 Miller PW. Radiolabelling with short-lived PET (positron emission tomography) isotopes using microfluidic reactors. J Chem Technol Biotechnol 2009;84:309-15. [DOI: 10.1002/jctb.2061] [Cited by in Crossref: 47] [Cited by in F6Publishing: 30] [Article Influence: 3.9] [Reference Citation Analysis]
5 Shetty D, Choi SY, Jeong JM, Lee JY, Hoigebazar L, Lee YS, Lee DS, Chung JK, Lee MC, Chung YK. Stable aluminium fluoride chelates with triazacyclononane derivatives proved by X-ray crystallography and 18F-labeling study. Chem Commun (Camb) 2011;47:9732-4. [PMID: 21776539 DOI: 10.1039/c1cc13151f] [Cited by in Crossref: 54] [Cited by in F6Publishing: 42] [Article Influence: 5.4] [Reference Citation Analysis]
6 Hong R, Lim SC. 18F-fluoro-2-deoxyglucose uptake on PET CT and glucose transporter 1 expression in colorectal adenocarcinoma. World J Gastroenterol 2012; 18(2): 168-174 [PMID: 22253523 DOI: 10.3748/wjg.v18.i2.168] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
7 Wang J, Zhang Y, Yang W, Xue J, Liu Y. 99mTc-labeled colchicine for tumor imaging using DTPA as bifunctional chelating agent. J Radioanal Nucl Chem 2016;307:1087-92. [DOI: 10.1007/s10967-015-4308-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
8 Mauri G, Gennaro N, De Beni S, Ierace T, Goldberg SN, Rodari M, Solbiati LA. Real-Time US-18FDG-PET/CT Image Fusion for Guidance of Thermal Ablation of 18FDG-PET-Positive Liver Metastases: The Added Value of Contrast Enhancement. Cardiovasc Intervent Radiol 2019;42:60-8. [PMID: 30288593 DOI: 10.1007/s00270-018-2082-1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 7.7] [Reference Citation Analysis]
9 Mu L, Höhne A, Schubiger PA, Ametamey SM, Graham K, Cyr JE, Dinkelborg L, Stellfeld T, Srinivasan A, Voigtmann U, Klar U. Silicon-based building blocks for one-step 18F-radiolabeling of peptides for PET imaging. Angew Chem Int Ed Engl 2008;47:4922-5. [PMID: 18496798 DOI: 10.1002/anie.200705854] [Cited by in Crossref: 87] [Cited by in F6Publishing: 80] [Article Influence: 6.7] [Reference Citation Analysis]
10 Subbarayan P, Wang P, Lampidis T, Ardalan B, Braunschweiger P. Differential Expression of Glut 1 mRNA and Protein Levels Correlates with Increased Sensitivity to the Glyco-Conjugated Nitric Oxide Donor (2-glu-SNAP) in Different Tumor Cell Types. Journal of Chemotherapy 2013;20:106-11. [DOI: 10.1179/joc.2008.20.1.106] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
11 Haji Dheere AK, Bongarzone S, Shakir D, Gee A. Direct Incorporation of [11C]CO2 into Asymmetric [11C]Carbonates. J Chem 2018;2018:7641304. [PMID: 34079623 DOI: 10.1155/2018/7641304] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
12 Richter JP, Goroncy AK, Ronimus RS, Sutherland-Smith AJ. The Structural and Functional Characterization of Mammalian ADP-dependent Glucokinase. J Biol Chem 2016;291:3694-704. [PMID: 26555263 DOI: 10.1074/jbc.M115.679902] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
13 Kaira K, Oriuchi N, Imai H, Shimizu K, Yanagitani N, Sunaga N, Hisada T, Kawashima O, Kamide Y, Ishizuka T. Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in surgically resectable stage III non-small cell lung cancer. Exp Ther Med. 2010;1:799-808. [PMID: 22993604 DOI: 10.3892/etm.2010.117] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
14 Kaira K, Oriuchi N, Shimizu K, Tominaga H, Yanagitani N, Sunaga N, Ishizuka T, Kanai Y, Mori M, Endo K. 18 F-FMT Uptake Seen Within Primary Cancer on PET Helps Predict Outcome of Non–Small Cell Lung Cancer. J Nucl Med 2009;50:1770-6. [DOI: 10.2967/jnumed.109.066837] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 3.1] [Reference Citation Analysis]
15 Sunaga N, Oriuchi N, Kaira K, Yanagitani N, Tomizawa Y, Hisada T, Ishizuka T, Endo K, Mori M. Usefulness of FDG-PET for early prediction of the response to gefitinib in non-small cell lung cancer. Lung Cancer. 2008;59:203-210. [PMID: 17913282 DOI: 10.1016/j.lungcan.2007.08.012] [Cited by in Crossref: 100] [Cited by in F6Publishing: 90] [Article Influence: 7.1] [Reference Citation Analysis]
16 Vera-Sirera B, Forner-Navarro L, Vera-Sempere F. Immunohistochemical expression of glucose transporter 1 in keratin-producing odontogenic cysts. BMC Oral Health 2016;16:32. [PMID: 26965170 DOI: 10.1186/s12903-016-0191-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
17 Mu L, Höhne A, Schubiger P, Ametamey S, Graham K, Cyr J, Dinkelborg L, Stellfeld T, Srinivasan A, Voigtmann U, Klar U. Siliciumbausteine für eine einstufige18F-Radiomarkierung von Peptiden für die PET-Bildgebung. Angew Chem 2008;120:5000-3. [DOI: 10.1002/ange.200705854] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
18 Waerzeggers Y, Ullrich RT, Monfared P, Viel T, Weckesser M, Stummer W, Schober O, Winkeler A, Jacobs AH. Specific biomarkers of receptors, pathways of inhibition and targeted therapies: clinical applications. Br J Radiol 2011;84 Spec No 2:S179-95. [PMID: 22433828 DOI: 10.1259/bjr/76389842] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
19 Kaira K, Oriuchi N, Shimizu K, Imai H, Tominaga H, Yanagitani N, Sunaga N, Hisada T, Ishizuka T, Kanai Y, Oyama T, Mori M, Endo K. Comparison of L-type amino acid transporter 1 expression and L-[3-18F]-α-methyl tyrosine uptake in outcome of non-small cell lung cancer. Nucl Med Biol 2010;37:911-6. [PMID: 21055621 DOI: 10.1016/j.nucmedbio.2010.06.004] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
20 Kim BH, Na MA, Kim IJ, Kim S, Kim Y. Risk stratification and prediction of cancer of focal thyroid fluorodeoxyglucose uptake during cancer evaluation. Ann Nucl Med 2010;24:721-8. [DOI: 10.1007/s12149-010-0414-6] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 2.7] [Reference Citation Analysis]
21 Paudyal B, Oriuchi N, Paudyal P, Higuchi T, Nakajima T, Endo K. Expression of glucose transporters and hexokinase II in cholangiocellular carcinoma compared using [18F]-2-fluro-2-deoxy-D-glucose positron emission tomography. Cancer Sci. 2008;99:260-266. [PMID: 18271924 DOI: 10.1111/j.1349-7006.2007.00683.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 2.9] [Reference Citation Analysis]
22 Scott P. Methoden für den Einbau von Kohlenstoff-11 zur Erzeugung von Radiopharmaka für die Positronenemissionstomographie. Angew Chem 2009;121:6115-8. [DOI: 10.1002/ange.200901481] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
23 Sunaga N, Kaira K, Hisada T, Yamada M. FDG-PET for predicting efficacy of EGFR-tyrosine kinase inhibitors in lung cancer. World J Respirol 2013; 3(3): 104-109 [DOI: 10.5320/wjr.v3.i3.104] [Reference Citation Analysis]
24 Yamada T, Uchida M, Kwang-lee K, Kitamura N, Yoshimura T, Sasabe E, Yamamoto T. Correlation of metabolism/hypoxia markers and fluorodeoxyglucose uptake in oral squamous cell carcinomas. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 2012;113:464-71. [DOI: 10.1016/j.tripleo.2011.04.006] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 4.4] [Reference Citation Analysis]
25 Clapp AJ, Peller PJ, Subramaniam RM. AJR Teaching File: Incidental Breast Cancer Detected With 18 F-FDG PET/CT. American Journal of Roentgenology 2011;196:WS83-5. [DOI: 10.2214/ajr.10.7243] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
26 I HS, Kim S, Kim IJ, Kim K. Predictive Value of Metabolic Tumor Volume Measured by 18F-FDG PET for Regional Lymph Node Status in Patients With Esophageal Cancer. Clinical Nuclear Medicine 2012;37:442-6. [DOI: 10.1097/rlu.0b013e318238f703] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
27 Pinilla I, Rodríguez-Vigil B, Gómez-León N. Integrated FDG PET/CT: Utility and Applications in Clinical Oncology. Clin Med Oncol 2008;2:181-98. [PMID: 21892279 DOI: 10.4137/cmo.s504] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
28 Chen Y, Xiong Q, Yang X, Huang Z, Zhao Y, He L. Noninvasive Scintigraphic Detection of Tumor with 99m Tc-DTPA-Deoxyglucose: An Experimental Study. Cancer Biotherapy and Radiopharmaceuticals 2007;22:403-5. [DOI: 10.1089/cbr.2006.327] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
29 Takano A, Oriuchi N, Tsushima Y, Taketomi-takahashi A, Nakajima T, Arisaka Y, Higuchi T, Amanuma M, Endo K. Detection of metastatic lesions from malignant pheochromocytoma and paraganglioma with diffusion-weighted magnetic resonance imaging: comparison with 18F-FDG positron emission tomography and 123I-MIBG scintigraphy. Ann Nucl Med 2008;22:395-401. [DOI: 10.1007/s12149-008-0128-1] [Cited by in Crossref: 40] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
30 Tong S, Lee J, Ki K, Choi Y, Seol H, Lee S, Huh C, Kim G, Lim S. Correlation Between FDG Uptake by PET/CT and the Expressions of Glucose Transporter Type 1 and Hexokinase II in Cervical Cancer: . International Journal of Gynecological Cancer 2012;22:654-8. [DOI: 10.1097/igc.0b013e31824864e6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
31 Haji Dheere AK, Yusuf N, Gee A. Rapid and efficient synthesis of [11C]ureas via the incorporation of [11C]CO2 into aliphatic and aromatic amines. Chem Commun 2013;49:8193. [DOI: 10.1039/c3cc44046j] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
32 Kaira K, Oriuchi N, Imai H, Shimizu K, Yanagitani N, Sunaga N, Hisada T, Kawashima O, Iijima H, Ishizuka T. Expression of L-type amino acid transporter 1 (LAT1) in neuroendocrine tumors of the lung. Pathol Res Pract. 2008;204:553-561. [PMID: 18440724 DOI: 10.1016/j.prp.2008.02.003] [Cited by in Crossref: 42] [Cited by in F6Publishing: 46] [Article Influence: 3.2] [Reference Citation Analysis]
33 Brugarolas P, Bhuiyan M, Kucharski A, Freifelder R. Automated Radiochemical Synthesis of [18F]3F4AP: A Novel PET Tracer for Imaging Demyelinating Diseases. J Vis Exp 2017. [PMID: 28605366 DOI: 10.3791/55537] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
34 Kaira K, Oriuchi N, Imai H, Shimizu K, Yanagitani N, Sunaga N, Hisada T, Tanaka S, Ishizuka T, Kanai Y. Prognostic significance of L-type amino acid transporter 1 expression in resectable stage I-III nonsmall cell lung cancer. Br J Cancer. 2008;98:742-748. [PMID: 18253116 DOI: 10.1038/sj.bjc.6604235] [Cited by in Crossref: 145] [Cited by in F6Publishing: 140] [Article Influence: 11.2] [Reference Citation Analysis]
35 Kaira K, Oriuchi N, Imai H, Shimizu K, Yanagitani N, Sunaga N, Hisada T, Tanaka S, Ishizuka T, Kanai Y, Endou H, Nakajima T, Mori M. l-type amino acid transporter 1 and CD98 expression in primary and metastatic sites of human neoplasms. Cancer Sci 2008;99:2380-6. [PMID: 19018776 DOI: 10.1111/j.1349-7006.2008.00969.x] [Cited by in Crossref: 98] [Cited by in F6Publishing: 96] [Article Influence: 7.5] [Reference Citation Analysis]
36 Kalyane D, Raval N, Maheshwari R, Tambe V, Kalia K, Tekade RK. Employment of enhanced permeability and retention effect (EPR): Nanoparticle-based precision tools for targeting of therapeutic and diagnostic agent in cancer. Mater Sci Eng C Mater Biol Appl 2019;98:1252-76. [PMID: 30813007 DOI: 10.1016/j.msec.2019.01.066] [Cited by in Crossref: 181] [Cited by in F6Publishing: 158] [Article Influence: 90.5] [Reference Citation Analysis]
37 Miller P, Long N, Vilar R, Gee A. Synthesis of 11 C, 18 F, 15 O, and 13 N Radiolabels for Positron Emission Tomography. Angew Chem Int Ed 2008;47:8998-9033. [DOI: 10.1002/anie.200800222] [Cited by in Crossref: 662] [Cited by in F6Publishing: 570] [Article Influence: 50.9] [Reference Citation Analysis]
38 Kawakita D, Masui T, Hanai N, Ozawa T, Hirakawa H, Terada A, Nishio M, Hosoi H, Hasegawa Y. Impact of positron emission tomography with the use of fluorodeoxyglucose on response to induction chemotherapy in patients with oropharyngeal and hypopharyngeal squamous cell carcinoma. Acta Oto-Laryngologica 2013;133:523-30. [DOI: 10.3109/00016489.2012.733411] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
39 Wang J, Yang J, Duan X, Zhang Y, Yang W, Liu Y. Synthesis and biological evaluation of 99mTc(CO)3(His–CB) as a tumor imaging agent. Bioorganic & Medicinal Chemistry Letters 2012;22:7406-9. [DOI: 10.1016/j.bmcl.2012.10.062] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
40 Kaira K, Oriuchi N, Imai H, Shimizu K, Yanagitani N, Sunaga N, Hisada T, Ishizuka T, Kanai Y, Endou H. Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in early stage squamous cell carcinoma of the lung. Cancer Sci. 2009;100:248-254. [PMID: 19068093 DOI: 10.1111/j.1349-7006.2008.01029.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 3.2] [Reference Citation Analysis]
41 Gehrig S, Sami H, Ogris M. Gene therapy and imaging in preclinical and clinical oncology: recent developments in therapy and theranostics. Therapeutic Delivery 2014;5:1275-96. [DOI: 10.4155/tde.14.87] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
42 Suzuki H, Fukuyama R, Hasegawa Y, Tamaki T, Nishio M, Nakashima T, Tatematsu M. Tumor thickness, depth of invasion, and Bcl-2 expression are correlated with FDG-uptake in oral squamous cell carcinomas. Oral Oncology 2009;45:891-7. [DOI: 10.1016/j.oraloncology.2009.03.009] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
43 Toyoshima J, Kusuhara H, Wempe MF, Endou H, Sugiyama Y. Investigation of the role of transporters on the hepatic elimination of an LAT1 selective inhibitor JPH203. J Pharm Sci 2013;102:3228-38. [PMID: 23712732 DOI: 10.1002/jps.23601] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
44 Dewalle-vignion A, Yeni N, Petyt G, Verscheure L, Huglo D, Béron A, Adib S, Lion G, Vermandel M. Evaluation of PET volume segmentation methods: comparisons with expert manual delineations. Nuclear Medicine Communications 2012;33:34-42. [DOI: 10.1097/mnm.0b013e32834d736f] [Cited by in Crossref: 23] [Cited by in F6Publishing: 6] [Article Influence: 2.6] [Reference Citation Analysis]
45 Lim S, Lee EH, Park JM, Chang YW, Kim HH, Jeong SH. Role of combined BI-RADS assessment using mammography and sonography for evaluation of incidental hypermetabolic lesions in the breast on 18F-FDG PET-CT. Acta Radiol 2013;54:1117-24. [PMID: 23864064 DOI: 10.1177/0284185113492453] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
46 Oriuchi N, Sugawara S, Shiga T. Positron Emission Tomography for Response Evaluation in Microenvironment-Targeted Anti-Cancer Therapy. Biomedicines 2020;8:E371. [PMID: 32972006 DOI: 10.3390/biomedicines8090371] [Reference Citation Analysis]
47 Miyakubo M, Oriuchi N, Tsushima Y, Higuchi T, Koyama K, Arai K, Paudyal B, Iida Y, Hanaoka H, Ishikita T, Nakasone Y, Negishi A, Mogi K, Endo K. Diagnosis of maxillofacial tumor withl-3-[18F]-fluoro-α-methyltyrosine (FMT) PET: a comparative study with FDG-PET. Ann Nucl Med 2007;21:129-35. [DOI: 10.1007/bf03033991] [Cited by in Crossref: 27] [Cited by in F6Publishing: 7] [Article Influence: 1.9] [Reference Citation Analysis]
48 Kim S, Kim Y, Kim IJ, Kim YD, Lee MK. Limited Predictive Value of Dual-Time-Point F-18 FDG PET/CT for Evaluation of Pathologic N1 Status in NSCLC Patients. Clinical Nuclear Medicine 2011;36:434-9. [DOI: 10.1097/rlu.0b013e31820adef8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
49 Kim S, Kim BH, Jeon YK, Kim SS, Kim IJ. Limited diagnostic and predictive values of dual-time-point 18F FDG PET/CT for differentiation of incidentally detected thyroid nodules. Ann Nucl Med 2011;25:347-53. [DOI: 10.1007/s12149-011-0468-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
50 Preshlock S, Tredwell M, Gouverneur V. (18)F-Labeling of Arenes and Heteroarenes for Applications in Positron Emission Tomography. Chem Rev 2016;116:719-66. [PMID: 26751274 DOI: 10.1021/acs.chemrev.5b00493] [Cited by in Crossref: 416] [Cited by in F6Publishing: 320] [Article Influence: 83.2] [Reference Citation Analysis]
51 Miller P, Long N, Vilar R, Gee A. Synthese von 11 C-, 18 F-, 15 O- und 13 N-Radiotracern für die Positronenemissionstomographie. Angew Chem 2008;120:9136-72. [DOI: 10.1002/ange.200800222] [Cited by in Crossref: 132] [Cited by in F6Publishing: 97] [Article Influence: 10.2] [Reference Citation Analysis]